Mechanisms of nuclear content loading to exosomes.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
11 2019
Historique:
received: 01 05 2019
accepted: 24 09 2019
entrez: 5 12 2019
pubmed: 5 12 2019
medline: 12 5 2020
Statut: epublish

Résumé

Exosome cargoes are highly varied and include proteins, small RNAs, and genomic DNA (gDNA). The presence of gDNA suggests that different intracellular compartments contribute to exosome loading, resulting in distinct exosome subpopulations. However, the loading of gDNA and other nuclear contents into exosomes (nExo) remains poorly understood. Here, we identify the relationship between cancer cell micronuclei (MN), which are markers of genomic instability, and nExo formation. Imaging flow cytometry analyses reveal that 10% of exosomes derived from cancer cells and <1% of exosomes derived from blood and ascites from patients with ovarian cancer carry nuclear contents. Treatment with genotoxic drugs resulted in increased MN and nExos both in vitro and in vivo. We observed that multivesicular body precursors and exosomal markers, such as the tetraspanins, directly interact with MN. Collectively, this work provides new insights related to nExos, which have implications for cancer biomarker development.

Identifiants

pubmed: 31799396
doi: 10.1126/sciadv.aax8849
pii: aax8849
pmc: PMC6867874
doi:

Substances chimiques

Biomarkers, Tumor 0
Tetraspanins 0
DNA 9007-49-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eaax8849

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA217685
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA209904
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA096300
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA083639
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA227622
Pays : United States
Organisme : NCATS NIH HHS
ID : UH2 TR000943
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA096297
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA098258
Pays : United States

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Références

Nat Commun. 2018 Jul 9;9(1):2658
pubmed: 29985392
Nat Rev Immunol. 2002 Aug;2(8):569-79
pubmed: 12154376
Gynecol Oncol. 2015 Aug;138(2):372-7
pubmed: 26050922
Cancer Treat Rev. 1994 Jan;20(1):73-96
pubmed: 8293429
Nature. 2018 Jan 25;553(7689):467-472
pubmed: 29342134
Elife. 2016 Aug 25;5:
pubmed: 27559612
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Biol Chem. 2016 Oct 21;291(43):22769-22780
pubmed: 27590341
Nature. 2012 Jan 18;482(7383):53-8
pubmed: 22258507
Nat Protoc. 2007;2(5):1084-104
pubmed: 17546000
J Biol Chem. 2013 Oct 18;288(42):30320-9
pubmed: 24003224
J Clin Invest. 2016 Apr 1;126(4):1163-72
pubmed: 26974161
Nat Rev Cancer. 2011 Jun;11(6):426-37
pubmed: 21562580
Cell. 2013 Jul 3;154(1):47-60
pubmed: 23827674
J Extracell Vesicles. 2017 Mar 7;6(1):1286095
pubmed: 28326170
Nat Rev Mol Cell Biol. 2015 Oct;16(10):625-38
pubmed: 26350076
Gynecol Oncol. 2017 Dec;147(3):695-704
pubmed: 29037806
J Extracell Vesicles. 2014 Sep 08;3:
pubmed: 25279113
Forensic Sci Int Genet. 2017 Jul;29:174-180
pubmed: 28448897
Nat Rev Dis Primers. 2016 Aug 25;2:16061
pubmed: 27558151
Nat Commun. 2017 May 16;8:15287
pubmed: 28508895
Mol Cell. 2012 Aug 24;47(4):497-510
pubmed: 22920291
Cell. 2019 Apr 4;177(2):428-445.e18
pubmed: 30951670
Cell Res. 2014 Jun;24(6):766-9
pubmed: 24710597
Nature. 2017 Aug 24;548(7668):466-470
pubmed: 28759889
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
J Biol Chem. 2014 Feb 14;289(7):3869-75
pubmed: 24398677
Nat Genet. 2018 Sep;50(9):1262-1270
pubmed: 30104763
Oncotarget. 2018 Sep 4;9(69):33056-33058
pubmed: 30237848
Nat Cell Biol. 2012 Feb 19;14(3):318-28
pubmed: 22344029
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Anal Biochem. 2010 Jan 1;396(1):69-75
pubmed: 19699175
Nat Commun. 2011 Feb 01;2:180
pubmed: 21285958
Histochem Cell Biol. 2008 Dec;130(6):1091-103
pubmed: 18987874
Nat Commun. 2018 Feb 7;9(1):532
pubmed: 29416038
Mutagenesis. 2011 Jan;26(1):125-32
pubmed: 21164193
Cytometry A. 2014 Sep;85(9):756-70
pubmed: 24903900
Exp Cell Res. 2009 May 15;315(9):1584-92
pubmed: 18930046
J Extracell Vesicles. 2013 May 27;2:
pubmed: 24009894
Mutat Res. 2002 Aug 26;519(1-2):37-48
pubmed: 12160890

Auteurs

Akira Yokoi (A)

Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Alejandro Villar-Prados (A)

Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Medicine, Stanford University, Stanford, CA, USA.

Paul Allen Oliphint (PA)

Department of Molecular Biosciences and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA.

Jianhua Zhang (J)

Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Xingzhi Song (X)

Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Peter De Hoff (P)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, La Jolla, CA, USA.

Robert Morey (R)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, La Jolla, CA, USA.
Bioinformatics and Systems Biology Graduate Program, University of California, San Diego, La Jolla, CA, USA.

Jinsong Liu (J)

Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jason Roszik (J)

Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Karen Clise-Dwyer (K)

Section of Transplant Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jared K Burks (JK)

Department of Leukemia and Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Theresa J O'Halloran (TJ)

Department of Molecular Biosciences and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA.

Louise C Laurent (LC)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, La Jolla, CA, USA.
Bioinformatics and Systems Biology Graduate Program, University of California, San Diego, La Jolla, CA, USA.

Anil K Sood (AK)

Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Center for RNA Interference and Non-Coding RNA, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH